Cell Therapeutics Appoints New Chief Medical OfficerMarketWatch (press release)… CTI's ongoing randomized controlled phase 3 clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have relapsed after one …and …
Cell Therapeutics Appoints New Chief Medical OfficerPR Newswire (press release)… CTI's ongoing randomized controlled phase 3 clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have relapsed after one …and …
Immunomedics Develops Potential New Treatment Regimen for Non …MarketWatch (press release)… they are combined with chemotherapy, such as rituximab + CHOP (R-CHOP) for … and rituximab + hyper-fractionated CVAD for mantle cell lymphoma (MCL).Immuno…
Cumberland Courier NewspapersHelping hand for Wamberal mum Janine PerryCumberland Courier NewspapersA drug called rituximab has given Mrs Perry relief for between three and four months. Trouble is, it costs $35000 for one treatment. “So far I have be…
Opposing ViewsBiovaxID Vaccine Shows High Overall Survival in Mantle Cell …Opposing ViewsThe results of the clinical trial showed that vaccination with BiovaxID following rituximab combination chemotherapy induced nearly universal T-cell immune …
Damon Runyon Cancer Research Foundation awards $3.3 million …EurekAlert (press release)Despite the promising activity of antibodies such as rituximab (Rituxan, targets CD20), trastuzumab (Herceptin, targets HER2), and cetuximab (Erbitux, targets …
ผู้ป่วยวอนยิ่งลักษณ์ลดเหลื่อมล้ำมะเร็ง บัตรทองไม่ได้ยาแพง มีแต่ขรก.เบิกได้ประชาชาติธุร…
ASCO: Bendamustine Held Superior to CHOP in Patients With Follicular, Indolent …Cancer NetworkBy Michael Kaufman | June 12, 2012 CHICAGO—The two-drug combination of bendamustine (Treanda) plus rituximab (Rituxan) is more effective and less toxic th…
Arthritis drugs could prolong livesUsay CompareResearchers from the German Rheumatism Centre in Berlin looked at the death rates of 9000 sufferers of the condition and found that rituximab could lower …and more »
Telegraph.co.ukLittle-used arthritis drugs could prolong lifeTelegraph.co.ukPatients taking rituximab, another type of biologic treatment, had about a 40 per cent lower chance of dying than those who had only taken DMARDS. Researchers from the German R…